Correlation Between Akero Therapeutics and Reviva Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Akero Therapeutics and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Reviva Pharmaceuticals.
Diversification Opportunities for Akero Therapeutics and Reviva Pharmaceuticals
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between Akero and Reviva is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Reviva Pharmaceuticals go up and down completely randomly.
Pair Corralation between Akero Therapeutics and Reviva Pharmaceuticals
Given the investment horizon of 90 days Akero Therapeutics is expected to generate 1.32 times less return on investment than Reviva Pharmaceuticals. But when comparing it to its historical volatility, Akero Therapeutics is 1.52 times less risky than Reviva Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Reviva Pharmaceuticals Holdings is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 487.00 in Reviva Pharmaceuticals Holdings on September 12, 2024 and sell it today you would lose (235.00) from holding Reviva Pharmaceuticals Holdings or give up 48.25% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akero Therapeutics vs. Reviva Pharmaceuticals Holding
Performance |
| Timeline |
| Akero Therapeutics |
| Reviva Pharmaceuticals |
Akero Therapeutics and Reviva Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akero Therapeutics and Reviva Pharmaceuticals
The main advantage of trading using opposite Akero Therapeutics and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
| Reviva Pharmaceuticals vs. Protalix Biotherapeutics | Reviva Pharmaceuticals vs. Eyepoint Pharmaceuticals | Reviva Pharmaceuticals vs. Sellas Life Sciences | Reviva Pharmaceuticals vs. In8bio Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |